Karo Pharma AB
Records under this name other than the patents Karo Pharma AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 4 of 4 · Back to Karo Pharma AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,974,776 | Estrogen receptor beta agonists for use in treating mesothelioma Formerly held Lapsed on the fee record Ended May 22, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2026 | From the USPTO record |
| US 8,367,665 | Estrogen receptor ligands Formerly held Lapsed on the fee record Ended Feb 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2025 | From the USPTO record |
| US 8,653,072 | Estrogen receptor ligands Formerly held Lapsed on the fee record Ended Feb 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 18, 2022 | From the USPTO record |
| US 9,586,891 | Estrogen receptor ligands Lapsed on the fee record Ended Mar 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 7, 2021 | From the USPTO record |